The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1225
ISSUE 1225
January 2, 2006
Issue 1225
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Statins for High-Risk Patients without Heart Disease or High Cholesterol
January 2, 2006 (Issue: 1225)
The FDA recently approved the use of atorvastatin (Lipitor) to reduce the risk of heart attack and stroke in patients without heart disease who have type 2 diabetes plus other risk factors, with or without hypercholesterolemia. The agency also...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.